Global Pharma CCO Market Analysis by Size, Share, Growth, Trends, Developments & Investments by 2027

A contract commercial organization (CCO) provides commercial services to pharmaceutical companies to optimize performance, reduce various risks, and expedite the delivery of healthcare advancements to patients. Some of the major services offered by CCOs are strategic consulting, market access (including RWE and HEOR), pricing and reimbursement, medical affairs, regulatory and compliance, and other services (data and analytics, and marketing services - HCP engagement, patient engagement, promotional strategies).

An Increasing Demand for Real-World Evidence (RWE) and Health Economics and Outcomes Research (HEOR) Propels the Pharma CCO Market Growth

Real-world data is the data relating to a patient's health status and/or the delivery of health care collected from multiple sources such as electronic health records (EHRs), medical claims and billing data, observational studies, patient-reported outcomes (PROs), patient-generated health data gathered from many medical devices. Regulatory bodies are rapidly using real-world data (RWD) and real-world evidence (RWE) to examine the post-market safety of approved drugs. RWE complements the clinical trial data by offering insights into safety and effectiveness data from a patient’s daily life. It has the potential to affect approvals and quicken the drug development process. Moreover, payors use real-world data to make coverage decisions, price negotiations and result-based contracting.

HEOR data includes observational data, price comparison, and various types of data that examines the economic impact of healthcare interventions, treatment, or medical conditions. It includes direct medical costs such as medications, hospital days, tests, indirect costs such as unpaid assistance, days lost from work, reduced productivity, and intangible costs such as pain. It is widely being used to generate evidence related to the value of new interventions for reimbursement agencies and local healthcare payers.

“The utilization of RWE and HEOR is projected to grow further in the upcoming years as it solves many issues such as product safety and risk concerns, cost justification of products, clinical trial designs.”-Marketing Director, Pharma CCO Service Provider, United States

Consolidation of Clinical Research Organization (CRO) & CCO Operations – A Promising Market Trend

Over the past few years, a number of CROs and CCO firms have achieved synergies by adding commercialization or CRO services to their portfolios through takeovers, which have allowed them to provide an ‘End-to-End’ solution to their pharmaceutical clients. 

For instance:

  • In July 2023, Catalyst Clinical Research, a oncology CRO acquired Genpro Research, a next-generation services and technology partner for the pharmaceutical, biotechnology, and medical devices market with expertise in biometrics, medical writing, RWE, and AI-enabled automation product development.

Competitive Landscape Analysis: Pharma CCO Market

Some of the established and top players operating in the global pharma CCO market are EVERSANA, IQVIA, Certara, Indegene, Real Chemistry, Lucid Group, Syneos Health, Genesis Research, Fishawack Health, Cheors, Peregrine.

The worldwide pharma CCO market is poised to experience a consistent growth in the upcoming years due to the rising move towards value-based care, dynamic regulatory policies, the demand to decrease healthcare costs, enrich patient results, reduce overall medical costs, and aggressive growth strategies implemented by the established market players.

Send An Enquiry to Get a FREE Sample PDF on Pharma CCO Market @ https://meditechinsights.com/pharma-contract-commercialization-cco-market/

Comments

Post a Comment

Popular posts from this blog

Global HPV Testing and PAP Test Market is slated to grow at a lucrative CAGR of 12 to 15 % by 2027 – Growing Revolution for the Prevention of Cervical Cancer

Cervical cancer is a malignant tumor which starts in the cells of the cervix, the lowermost part of the uterus. Cervical cancer begins when the cells on its surface transforms into precancerous cells. If not destroyed, these abnormal cells may turn into harmful cancer cells and spread in the cervix and surrounding areas. Cervical cancer screening involves HPV and PAP tests , which can identify HPV infection or pre-cancerous lesions at an early stage and if correct treatment is offered at the right time then the cancer can be prevented. Impact of  Covid-19 on  the Global HPV Testing and PAP Test Market Covid-19 pandemic had impacted the healthcare market in many ways. During Covid pandemic, due to strict social-distancing norms in hospitals, there was a delay in many diagnostic examinations and procedures. The delay in the cancer screening services due to the lack of skilled healthcare staff and disruption in the supply chain of testing kits across the world had led to a severe impact o
Read more

Global Drug Discovery Software market valued at $2 billion in 2020, is projected to grow at a healthy CAGR of 14% to reach $3.5 billion by 2025

The global drug discovery software market (such as ligand-based design, structure-based design, LIMS, ELN) is driven by the increasing R&D spend and pipeline, expanding scope and scale, increasing stringency of testing and regulations, growing number and size of biotechs, need for increasing cost efficiencies and reducing time to market, and move towards web/cloud-based software. Global Drug Discovery Software Market – Niche but Fast-Growing Market The worldwide drug discovery software market is niche and growing rapidly, driven by the rising pressure on the pharma and biotech companies to cut costs in the research and preclinical stage of drug development, reduce timelines and improve transparency through deep learning software tools. “ Large players present in this segment are trying to consolidate the market by becoming a one stop shop. Moreover, companies are also considering to combine their solutions with bioinformatics and LIMS tools to have a competitive edge .” - Exe
Read more

Global Genomics Market Report Reveals Rapid Growth & Transformative Trends in the Genomic Industry by 2027

In the ever-evolving landscape of healthcare, genomics is making headlines for its groundbreaking contributions to personalized medicine, disease understanding, and advancements in pharmaceutical research. The Global Genomics Market Report for 2023 highlights the impressive growth and transformative trends within the genomics industry, shedding light on the exciting potential of genomics in shaping the future of healthcare. I. The Genomics Market Landscape The report's comprehensive analysis of the global genomics market reveals a dynamic and rapidly expanding landscape. With a CAGR of over [X]% during the forecast period, the industry is experiencing unprecedented growth. Key factors driving this growth include increased adoption of genomics in clinical diagnostics, expanding genomics research initiatives, and the development of advanced sequencing technologies. II. Personalized Medicine Revolution One of the most exciting trends highlighted in the report is the integration of ge
Read more